chr1-43432382-T-G
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001365999.1(SZT2):c.5385T>G(p.Ser1795Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0289 in 1,600,920 control chromosomes in the GnomAD database, including 772 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001365999.1 synonymous
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0314 AC: 4782AN: 152154Hom.: 100 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0295 AC: 6997AN: 237500 AF XY: 0.0303 show subpopulations
GnomAD4 exome AF: 0.0287 AC: 41504AN: 1448648Hom.: 671 Cov.: 33 AF XY: 0.0291 AC XY: 20935AN XY: 720130 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0314 AC: 4784AN: 152272Hom.: 101 Cov.: 32 AF XY: 0.0317 AC XY: 2358AN XY: 74456 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
Developmental and epileptic encephalopathy, 18 Benign:1
- -
not specified Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at